| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/10/1999 | CN1207740A Novel intermediates and their use to prepare N,N'-bridged bisindolylmaleimides |
| 02/10/1999 | CN1207682A Method and material for hair therapy |
| 02/10/1999 | CN1207670A Cosmetic composition and method for reducing ageing processes of skin |
| 02/10/1999 | CN1207318A Ointment for treating burn and scald |
| 02/10/1999 | CN1042026C 25 carboxylic deriv. of vitamin D series, its preparing method, middle products in production of same and medicine contg. same and pharmaceutical use of same in treatment |
| 02/09/1999 | US5869711 Ceramide compounds, process for their preparation and use |
| 02/09/1999 | US5869663 Intermediates for neurokinin receptor antagonists |
| 02/09/1999 | US5869537 Macrophage lipid chemoattractant |
| 02/09/1999 | US5869534 Administering aminoguanidine and analogs thereof to reduce lipid oxidation and inhibit an increase in serum low density lipoproteins to prevent disease states characterized by the presence of advanced glycosylation endproducts |
| 02/09/1999 | US5869515 1,3-dihydro-2H-imidazol-2-one compounds |
| 02/09/1999 | US5869511 Isoxazoline compounds as inhibitors of TNF release |
| 02/09/1999 | US5869485 Treatment of diseases which respond to inhibition of the activity of the protein tyrosine kinase |
| 02/09/1999 | US5869470 Salicylic acid, retinoid |
| 02/09/1999 | US5869037 Adenoviral-mediated gene transfer to adipocytes |
| 02/09/1999 | US5869034 Use of sphingolipids in the preparation of a cosmetic or dermopharmaceutical composition protecting the skin and hair against the harmful effects of atmospheric pollution |
| 02/09/1999 | US5869031 Depigmenting dermatological and/or cosmetic composition |
| 02/09/1999 | CA2226091C Cyclosporin-containing soft capsule preparations |
| 02/05/1999 | CA2239817A1 Novel prokaryotic polynucleotides, polypeptides and their uses |
| 02/05/1999 | CA2239270A1 Novel phosphoribosyl transferase |
| 02/04/1999 | WO1999005180A1 Collagen type i and type iii adhesive compositions |
| 02/04/1999 | WO1999005113A1 Substituted 6-phenylphenanthridines |
| 02/04/1999 | WO1999005112A1 Substituted 6-alkylphenanthridines |
| 02/04/1999 | WO1999005111A1 Novel tetrazole derivatives |
| 02/04/1999 | WO1999005107A1 Vitronectin receptor antagonist |
| 02/04/1999 | WO1999004837A1 Blood product delivery system |
| 02/04/1999 | WO1999004821A2 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/04/1999 | WO1999004806A1 Methods and compositions for inhibiting angiogenesis |
| 02/04/1999 | WO1999004804A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | WO1999004752A2 Methods for treating skin pigmentation |
| 02/04/1999 | WO1999004628A1 Phototherapy based method for treating pathogens and composition for effecting same |
| 02/04/1999 | CA2308146A1 Collagen type i and type iii adhesive compositions |
| 02/04/1999 | CA2298526A1 Phototherapy based method for treating pathogens and composition for effecting same |
| 02/04/1999 | CA2298065A1 Immobilization of vitamin a acid by cationic polyelectrolytes |
| 02/04/1999 | CA2297923A1 Novel tetrazole-substituted 6-phenyl-pheanathridines as pde inhibitors |
| 02/04/1999 | CA2297910A1 Vitronectin receptor antagonist |
| 02/04/1999 | CA2297183A1 Maternal immune secretions and their use in the treatment and/or prophylaxis of conditions of the human body |
| 02/04/1999 | CA2267077A1 Methods for treating skin pigmentation |
| 02/03/1999 | EP0894855A2 Human I kappa B-beta transcription factor |
| 02/03/1999 | EP0894093A2 Soluble tachykinin antagonists, the preparation and use thereof |
| 02/03/1999 | EP0793649B1 18,19-dinor-vitamin d compounds |
| 02/03/1999 | EP0649274B1 Aqueous compositions comprising an organic peroxiacid |
| 02/03/1999 | CN1207044A Cyclosporin-containing soft capsule preparations |
| 02/03/1999 | CN1207042A A Pharmaceutical composition for the treatment of autommune diseases |
| 02/03/1999 | CN1206613A Process for preparing medicine for treating burn |
| 02/03/1999 | CN1206608A Prescription of medicine for curing superficial fungi and preparation process thereof |
| 02/03/1999 | CN1206599A Jieyinjing washing liquid for cleaning pudendum |
| 02/03/1999 | CN1041923C Piperzine derivatives and preparation process and usage thereof |
| 02/02/1999 | US5866703 With at least two different acids chosen from 6-desaturated essential fatty acids and oleic acid, useful in nutrition and in medicine. |
| 02/02/1999 | US5866693 Detecting mutations in the polynucleotides encoding the madr3 or madr4 and for detecting altered levels of the polypeptide in a host. |
| 02/02/1999 | US5866588 Dual histamine (h1) and platelet activating factor (paf) receptor antagonists. |
| 02/02/1999 | US5866540 Cyclic adhesion inhibitors |
| 02/02/1999 | US5866418 Filtration; ion exchanging; ulcers, gastrointestinal disorders |
| 02/02/1999 | US5866364 Recombinant bone morphogenetic protein heterodimers |
| 02/02/1999 | US5866168 Dermatological/pharmaceutical compositions comprising lanthanide, manganese, tin, zinc, yttrium, cobalt, barium and/or strontium salts as substance P antagonists |
| 02/02/1999 | US5866167 Culture product |
| 02/02/1999 | US5866157 Matrix patch formulation |
| 02/02/1999 | US5866105 Therapy for onychomycosis; topical applying nail varnish |
| 02/02/1999 | CA1340374C Oncogene-encoded polypeptide having growth factor activity and methods of production and use thereof |
| 01/29/1999 | CA2239266A1 Novel histidine kinase |
| 01/28/1999 | WO1999003886A1 Tropoelastin derivatives |
| 01/28/1999 | WO1999003854A1 Crystal modification of a n-phenyl-2-pyrimidineamine derivative, processes for its manufacture and its use |
| 01/28/1999 | WO1999003831A1 3-benzoylindole derivatives and drugs containing the same |
| 01/28/1999 | WO1999003826A2 Metalloproteinase inhibitors |
| 01/28/1999 | WO1999003505A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | WO1999003485A1 External preparations containing watercress extract |
| 01/28/1999 | WO1999003479A1 Lipid-based immune modulator composition |
| 01/28/1999 | WO1999003472A1 Peripherally acting anti-pruritic opiates |
| 01/28/1999 | WO1999003468A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 01/28/1999 | WO1999003459A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 01/28/1999 | WO1999003457A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 01/28/1999 | WO1999003455A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | WO1999003446A2 Antimicrobial cosmetic compositions |
| 01/28/1999 | DE19732139A1 Immobilisierung von Vitamin-A-Säure durch kationische Polyelektrolyte Immobilization of vitamin A acid by cationic polyelectrolytes |
| 01/28/1999 | CA2295690A1 Lipid-based immune modulator composition |
| 01/28/1999 | CA2294934A1 Gene therapy vehicle comprising dermal sheath tissue |
| 01/28/1999 | CA2294772A1 3-benzoylindole derivatives and drugs containing the same |
| 01/28/1999 | CA2289055A1 Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith |
| 01/28/1999 | CA2288833A1 Peripherally acting anti-pruritic opiates |
| 01/28/1999 | CA2288828A1 Kappa agonist anti-pruritic pharmaceutical formulations and method of treating pruritus therewith |
| 01/28/1999 | CA2288204A1 Film-forming compositions of antihyperalgesic opiates and method of treating hyperalgesic and pruritic conditions therewith |
| 01/28/1999 | CA2288132A1 Spray formulations of antihyperalgesic opiates and method of treating topical hyperalgesic conditions and pruritus therewith |
| 01/27/1999 | EP0893503A2 Regulator protein from Staphylococcus aureus |
| 01/27/1999 | EP0893493A2 Genetically modified cells and their use for prophylaxis or treatment of diseases |
| 01/27/1999 | EP0892849A1 Methods for using the obese gene and its gene product to stimulate hematopoietic development |
| 01/27/1999 | EP0892791A1 Substituted benzenesulfonamide derivatives as prodrugs of cox-2 inhibitors |
| 01/27/1999 | EP0892789A1 Irreversible inhibitors of tyrosine kinases |
| 01/27/1999 | EP0892644A1 $i(IN VIVO) GENE TRANSFER METHODS FOR WOUND HEALING |
| 01/27/1999 | EP0892642A1 Use in a composition of an extract of at least one labiate |
| 01/27/1999 | EP0892634A1 Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne |
| 01/27/1999 | EP0892633A2 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 01/27/1999 | EP0892632A1 Compositions useful in the phototherapeutic treatment of proliferative skin disorders |
| 01/27/1999 | CN1206414A N-acyl-2-substituted-4-(benzimidazolyl-or imidazopyridinyl-substituted pesidues)-piperidines as tachykinin antagonists |
| 01/27/1999 | CN1206405A Imides as PDE III, PDE IV and TNF inhibitors |
| 01/27/1999 | CN1206348A Extracts of shark cartilage |
| 01/27/1999 | CN1205883A Preparation of scald ointment |
| 01/26/1999 | US5864036 Substituted imidazole compounds |
| 01/26/1999 | US5863949 Reacting carboxylic acid derivative with 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide, 1-hydroxybenzenetriazole and hydroxylamine; treats diseases involving production of tumor necrosis factor in a mammal |
| 01/26/1999 | US5863942 Retinoid conjugate compounds useful for the treatment of aging skin |
| 01/26/1999 | US5863938 Wound healing agent comprises pyruvate selected from the group consisting of pyruvic acid, pharmaceutically acceptable salts of pyruvic acid and mixtures thereof; antioxidant; mixture of saturated and unsaturated fatty acids |
| 01/26/1999 | US5863927 Dextromethorphan and an oxidase inhibitor for treating intractable conditions |